Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15408 | 643 | 30.4 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
669 | 12548 | PSORIASIS//PSORIATIC ARTHRITIS//CALCIPOTRIOL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACRODERMATITIS CONTINUA OF HALLOPEAU | Author keyword | 10 | 73% | 1% | 8 |
2 | VOCLOSPORIN | Author keyword | 7 | 64% | 1% | 7 |
3 | MICROEMULSION FORMULATION | Author keyword | 1 | 50% | 0% | 2 |
4 | SEVERE PSORIASIS | Author keyword | 1 | 50% | 0% | 2 |
5 | ISA247 | Author keyword | 1 | 40% | 0% | 2 |
6 | LOW DOSE CYCLOSPORINE | Author keyword | 1 | 40% | 0% | 2 |
7 | INTERMITTENT APPLICATION | Author keyword | 1 | 33% | 0% | 2 |
8 | 1500 E MED DR | Address | 1 | 50% | 0% | 1 |
9 | ACNEIFORM LESIONS | Author keyword | 1 | 50% | 0% | 1 |
10 | ACRODERMATITIS CONTINUA SUPPURATIVA | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LOW DOSE CYCLOSPORINE | 26 | 24% | 15% | 94 |
2 | INTERMITTENT SHORT COURSES | 14 | 55% | 3% | 17 |
3 | INTRALESIONAL CYCLOSPORINE | 11 | 78% | 1% | 7 |
4 | LOW DOSE CYCLOSPORIN | 11 | 78% | 1% | 7 |
5 | ISATX247 | 9 | 83% | 1% | 5 |
6 | NEORALR | 5 | 41% | 1% | 9 |
7 | SEVERE LICHEN PLANUS | 4 | 67% | 1% | 4 |
8 | DC ART | 4 | 75% | 0% | 3 |
9 | ISA247 | 4 | 75% | 0% | 3 |
10 | SEVERE RECALCITRANT PSORIASIS | 3 | 37% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Acrodermatitis continua of Hallopeau (ACH): Two cases successfully treated with adalimumab | 2014 | 2 | 31 | 81% |
Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology | 2012 | 7 | 77 | 64% |
Cyclosporine consensus conference: With emphasis on the treatment of psoriasis | 1998 | 94 | 53 | 43% |
Treatment of Acrodermatitis Continua of Hallopeau with TNF-Blocking Agents: Case Report and Review | 2010 | 7 | 22 | 82% |
The use of ciclosporin in psoriasis | 2005 | 30 | 163 | 44% |
CYCLOSPORINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN IMMUNOREGULATORY DISORDERS | 1993 | 374 | 674 | 14% |
Acrodermatitis continua of Hallopeau: evolution of treatment options | 2011 | 4 | 51 | 51% |
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference | 2010 | 24 | 91 | 30% |
Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis | 2000 | 31 | 57 | 28% |
Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels | 2002 | 18 | 28 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 1500 E MED DR | 1 | 50% | 0.2% | 1 |
2 | CHAIR PHARMACOL CLIN PHARMACOL TOXICOL | 1 | 50% | 0.2% | 1 |
3 | DISCOVERY RD CHEM | 1 | 50% | 0.2% | 1 |
4 | MED SURG DERMATOL | 1 | 50% | 0.2% | 1 |
5 | MINIST HLTH ANKARA DISK I YILDIRIM | 1 | 50% | 0.2% | 1 |
6 | RHEUMA EINHEIT MED POLIKLIN | 1 | 50% | 0.2% | 1 |
7 | STATE DERMATOL VENEREOL | 0 | 33% | 0.2% | 1 |
8 | TJL PHARM HLTH SCI | 0 | 33% | 0.2% | 1 |
9 | DERMATOL INPATIENT SERV | 0 | 25% | 0.2% | 1 |
10 | IMMACOLATA DERMATOL | 0 | 20% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000147116 | AUTORADIOGRAPHIC TRACKING//BOVINE SERUM ALBUMIN NEPHRITIS//CIENCIAS CLIN 1 |
2 | 0.0000126253 | CYCLOSPORINE G//CYCLOSPORINE METABOLITES//CYCLOSPORIN G |
3 | 0.0000124636 | PSORIASIS//TAIYUAN CITY HOSP//MOUSE TAIL TEST |
4 | 0.0000114567 | CYCLOSPORINE A//CYCLOSPORINE NEPHROTOXICITY//NEPHROL HEM HE E TRANSPLANTAT |
5 | 0.0000110830 | CHILDHOOD PSORIASIS//JUVENILE PSORIASIS//PERIANAL STREPTOCOCCAL DERMATITIS |
6 | 0.0000104018 | METHOTREXATE//METHOTREXATE POLYGLUTAMATES//MX 68 |
7 | 0.0000102552 | PSORIASIS//EFALIZUMAB//ALEFACEPT |
8 | 0.0000097341 | CALCIPOTRIOL//BETAMETHASONE DIPROPIONATE//TACALCITOL |
9 | 0.0000085869 | D PENICILLAMINE//MESANGIAL GLOMERULOPATHY//ANTIACETYLCHOLINE RECEPTOR ANTIBODIES |
10 | 0.0000077411 | NEORAL//C2 MONITORING//C 2 MONITORING |